Immunic, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

Immunic, Inc. (IMUX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 80.00% for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2026-05-13

Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2026-03-31 was 80.00%.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 3 month	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 month
2026-03-31	80.00% 10-Q · filed 2026-05-13
2025-12-31		65.00% 10-Q · filed 2026-05-13

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
INOVIO PHARMACEUTICALS, INC. (INO)	United States	$0.125B	-1.35
MEDICINOVA INC (MNOV)	United States	$0.130B	-6.04
NRX Pharmaceuticals, Inc. (NRXP)	United States	$0.131B	-6.31
Aardvark Therapeutics, Inc. (AARD)	United States	$0.121B	-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)	United States	$0.121B	-8.95
Coya Therapeutics, Inc. (COYA)	United States	$0.121B	-6.35
Unicycive Therapeutics, Inc. (UNCY)	United States	$0.134B	-3.70
TuHURA Biosciences, Inc./NV (HURA)	United States	$0.134B	-4.88
OnKure Therapeutics, Inc. (OKUR)	United States	$0.119B	-3.13
Curanex Pharmaceuticals Inc (CURX)	United States	$0.138B